Page last updated: 2024-10-31

methyl methanesulfonate and Chagas Disease

methyl methanesulfonate has been researched along with Chagas Disease in 1 studies

Chagas Disease: Infection with the protozoan parasite TRYPANOSOMA CRUZI, a form of TRYPANOSOMIASIS endemic in Central and South America. It is named after the Brazilian physician Carlos Chagas, who discovered the parasite. Infection by the parasite (positive serologic result only) is distinguished from the clinical manifestations that develop years later, such as destruction of PARASYMPATHETIC GANGLIA; CHAGAS CARDIOMYOPATHY; and dysfunction of the ESOPHAGUS or COLON.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Beltran-Hortelano, I1
Atherton, RL1
Rubio-Hernández, M1
Sanz-Serrano, J1
Alcolea, V1
Kelly, JM1
Pérez-Silanes, S1
Olmo, F1

Other Studies

1 other study available for methyl methanesulfonate and Chagas Disease

ArticleYear
Design and synthesis of Mannich base-type derivatives containing imidazole and benzimidazole as lead compounds for drug discovery in Chagas Disease.
    European journal of medicinal chemistry, 2021, Nov-05, Volume: 223

    Topics: Benzimidazoles; Cell Line; Cell Proliferation; Chagas Disease; Drug Design; Humans; Imidazoles; Life

2021